Capital One Bank is holding a bank teller job fair on Tuesday,December 14 from 9:00 a.m. to 2:00 p.m. at
Capital One Headquarters
Dining Room A,3rd Floor
1680 Capital One Drive
McClean,VA 22102
You are invited to join them to learn more about Teller opportunities in Maryland,DC and Virginia and what to expect during their online application process.For more information,please visit www.capitalone.com/careers
Capital One:Better.Together.
Sunday, December 12, 2010
Saturday, December 11, 2010
Thursday, December 9, 2010
Newsletter Publisher:Don't Give Up On Big Pharma
Big pharmaceutical companies are often plagued by patent expirations on major products.That doesn't mean you should stop investing in them,prominent money manager and commentator Alan Lancz(pronounced Lance)points out.A frequent guest on business television,Mr.Lancz likes drugmakers Pfizer and Merck at this time.
Pfizer and Merck offer good dividend yields.As well,while stock analysts focus on their patent expirations,you don't often hear about their acquisitions or drug pipelines,such as Pfizer's acquisition of Wyeth and King Pharmaceuticals.
In the case of medical device maker Hologic,Mr.Lancz feels it's a bit toppy right now,but should be purchased at the buy limit of 17.00 or below.It closed at 17.55 on Thursday.
Hologic develops,manufactures and supplies diagnostics,medical imaging systems and surgical products for women's health needs,such as breast health products and GYN surgical products.
Alan B. Lancz is publisher of The Lancz Letter,a subscription-only newsletter that gives current recommendations and analysis on stocks,bonds,real estate,currencies and other related investment vehicles.
Pfizer(PFE),Merck(MRK),Hologic(HOLX)
Pfizer and Merck offer good dividend yields.As well,while stock analysts focus on their patent expirations,you don't often hear about their acquisitions or drug pipelines,such as Pfizer's acquisition of Wyeth and King Pharmaceuticals.
In the case of medical device maker Hologic,Mr.Lancz feels it's a bit toppy right now,but should be purchased at the buy limit of 17.00 or below.It closed at 17.55 on Thursday.
Hologic develops,manufactures and supplies diagnostics,medical imaging systems and surgical products for women's health needs,such as breast health products and GYN surgical products.
Alan B. Lancz is publisher of The Lancz Letter,a subscription-only newsletter that gives current recommendations and analysis on stocks,bonds,real estate,currencies and other related investment vehicles.
Pfizer(PFE),Merck(MRK),Hologic(HOLX)
Sunday, December 5, 2010
Wal-Mart Tussles With Safeway
The Christmas shopping season isn't just significant for gift sellers;but for grocers as well.Wal-Mart,for instance,thinks it is so important that it took on Safeway in a newspaper circular.Wal-Mart claims that a comparable basket of non-meat/non-produce frequently purchased items is 25% less expensive at their stores than at Safeway's.
Wal-Mart says it compared the average national prices for 244 items at their respective stores every week beginning September 25.Besides this aggressive tactic,Wal-Mart is making a pledge to match any local competitor's price in a printed ad for an identical product.
On the other hand,Safeway offers considerable discounts to holders of its Club Card,which were probably not taken into account by Wal-Mart.The Safeway Club Card is free and is issued upon the filling out of a brief application.
In China,Wal-Mart is opening smaller stores to serve lower income small town and rural residents.
Wal-Mart(WMT),Safeway(SWY)
Wal-Mart says it compared the average national prices for 244 items at their respective stores every week beginning September 25.Besides this aggressive tactic,Wal-Mart is making a pledge to match any local competitor's price in a printed ad for an identical product.
On the other hand,Safeway offers considerable discounts to holders of its Club Card,which were probably not taken into account by Wal-Mart.The Safeway Club Card is free and is issued upon the filling out of a brief application.
In China,Wal-Mart is opening smaller stores to serve lower income small town and rural residents.
Wal-Mart(WMT),Safeway(SWY)
A Brandeis Perspective:Black Swan of a Jobs Report
The duration of unemployment today and the slowness of the labor market's recovery are unprecedented.This observation was reinforced by Friday's bleak Labor Department unemployment report,which revealed a jobs gain of only 39,000,and an increase in the unemployment rate from 9.6-9.8%.Lisa Lynch,Dean of The Heller School for Social Policy and Management at Brandeis University in Waltham,Massachusetts,described the report as a huge surprise.Even the most pessimistic economists were not coming in with so low a number.We should be adding 120,000 jobs just to keep pace with population growth.
Dean Lynch pointed out there was much lower growth in the manufacturing sector,in spite of the demand for autos.There was also contraction in the construction and retail sectors.We did see growth in health care and restaurants and bars.
Those who are working are putting in more hours.Seeing their friends and family members out of work,they are hesitant to shop.
At this rate,it will take the labor market about 12.5 years to recover,Bloomberg Television calculated.
Lisa Lynch received her BA from Wellesley College and a PhD from the London School of Economics and Political Science.She has been in her position since 2008,and is also a Professor of Economics at Brandeis.
Dean Lynch pointed out there was much lower growth in the manufacturing sector,in spite of the demand for autos.There was also contraction in the construction and retail sectors.We did see growth in health care and restaurants and bars.
Those who are working are putting in more hours.Seeing their friends and family members out of work,they are hesitant to shop.
At this rate,it will take the labor market about 12.5 years to recover,Bloomberg Television calculated.
Lisa Lynch received her BA from Wellesley College and a PhD from the London School of Economics and Political Science.She has been in her position since 2008,and is also a Professor of Economics at Brandeis.
Inside Sales Open House
SenecaOne,a provider of financial services for lottery winners,prize winners and structured settlement recipients,is holding an open house for inside sales professionals.It will be held on Tuesday,December 7th from 4-8 pm at
Marriott Hotel(Bethesda)
5151 Pooks Hill Road
Bethesda,MD 20814
Free hotel parking will be provided.
2-5 years of cold calling and inside sales experience are a plus.Please bring your resume,dress professionally and be prepared for on the spot interviews.Those who can't attend should send their resumes to careers@senecaone.com
The 1st year income potential is 55-75K,and 2nd year potential is 100K+.
SenecaOne-your trusted source
Marriott Hotel(Bethesda)
5151 Pooks Hill Road
Bethesda,MD 20814
Free hotel parking will be provided.
2-5 years of cold calling and inside sales experience are a plus.Please bring your resume,dress professionally and be prepared for on the spot interviews.Those who can't attend should send their resumes to careers@senecaone.com
The 1st year income potential is 55-75K,and 2nd year potential is 100K+.
SenecaOne-your trusted source
Thursday, December 2, 2010
MedImmune's Oncology Portfolio Advances
MedImmune,the biologics business of British pharma titan AstraZeneca,is perhaps best known for its FluMist product,but it is also quite active in oncology innovation.They are using insights and understanding of cancer to discover breakthrough biologic therapies that can be used to treat specific cancers for the individual patient,according to Jerry McMahon,PhD,Senior Vice President and Oncology Innovative Medicines Unit Leader.
MedImmune's pipeline is focused on eliminating cancer cells in more effective and targeted ways.They are currently researching their products MEDI-575,an antibody with promise in treatment of solid tumors;and the immunotoxin moxetamomab pasudotox(CAT 8015),which is being evaluated for therapeutic potential against certain leukemias.
These are early phase studies,but MedImmune is excited about the oncology portfolio's progress and looks forward to advancing oncology products into expanded clinical studies in the near future,Dr.McMahon indicated.
MedImmune,based in Gaithersburg,Maryland,employs about 3500 people worldwide.Jerry McMahon,who assumed his position in October,received a doctorate in Biochemistry and Genetics from Rensselaer Polytechnic Institute in Troy,New York.
AstraZeneca(AZN)
MedImmune's pipeline is focused on eliminating cancer cells in more effective and targeted ways.They are currently researching their products MEDI-575,an antibody with promise in treatment of solid tumors;and the immunotoxin moxetamomab pasudotox(CAT 8015),which is being evaluated for therapeutic potential against certain leukemias.
These are early phase studies,but MedImmune is excited about the oncology portfolio's progress and looks forward to advancing oncology products into expanded clinical studies in the near future,Dr.McMahon indicated.
MedImmune,based in Gaithersburg,Maryland,employs about 3500 people worldwide.Jerry McMahon,who assumed his position in October,received a doctorate in Biochemistry and Genetics from Rensselaer Polytechnic Institute in Troy,New York.
AstraZeneca(AZN)
Subscribe to:
Posts (Atom)